Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Wuzhong Pharmaceutical Group Suzhou Pharmaceutical Factory is a prominent Chinese pharmaceutical manufacturer and a core subsidiary of the publicly traded Jiangsu Wuzhong Industrial Co., Ltd. The company operates as an integrated pharmaceutical enterprise, encompassing research and development, large-scale manufacturing, and commercial distribution. Its diverse product portfolio includes chemical drugs, biological products, and traditional Chinese medicines, with a strong emphasis on anti-infective, antiviral, and gastrointestinal therapies. Notably, the company is a leading producer of Arbidol (Umifenovir) in China and has recently pivoted towards the high-growth medical aesthetics market through strategic licensing and development of injectable fillers. With multiple GMP-certified production lines, it serves both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Wuzhong Pharmaceutical Group Suzhou Pharmaceutical Factory.